Clinical Pearls of Opioid Prescribing
This course discusses when to prescribe opioids to treat pain and how to appropriately formulate a treatment plan that adheres to the CDC Clinical Guidelines for opioid prescribing.
Target Audience
All Prescribers of Controlled Substances
MD/DO
Advanced Practice Clinicians
Registered Nurses
Learning Objectives
- Describe risks and benefits of opioid therapy for acute and chronic pain
- Explain the link between opioids and the neurobiology of addiction
- Formulate a patient treatment plan that optimizes opioid and non-opioid pharmacologic treatment, non-pharmacologic supports and utilizes available guidelines and community resources reflective of a multidisciplinary approach
- Utilize available guidelines and community resources reflective of a multidisciplinary approach when creating a pain management plan
Don Teater, MD, MPH is a board-certified family physician who has practiced medicine for over 30 years. Since 2013 he has focused mostly on the treatment of pain and addiction. From 2013 to mid-2016, he worked as the Medical Advisor at the National Safety Council addressing the national epidemic of opioid abuse, addiction, and overdose. Dr. Teater was lead facilitator for the expert panel during the development of the CDC Guideline for Prescribing Opioids for Chronic Pain 2016. He continues to work as a consultant with federal and state organizations. He also educates prescribers nationally on the appropriate treatment of pain and opioid use disorder. Don continues to see patients one day a week treating the disease of addiction via telemedicine from his home in Denver, CO to his patients in North Carolina. He is also a pain and addiction specialist for Southeast Alaska Regional Health Consortium in Juneau, AK.
Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Compass Healthcare Collaborative and Colorado Consortium for Prescription Drug Abuse Prevention. Compass Healthcare Collaborative is accredited by the IMS to provide continuing medical education for physicians.
Designation: Compass designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support: This activity was developed without support from any ineligible company. *The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.
Disclosure: Compass adheres to the Standards for Integrity and Independence in Accredited Continuing Education. The content of this activity is not related to products or the business lines of an ACCME-defined ineligible company. None of the planners or moderators for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or on patients.
Available Credit
- 1.00 AMA PRA Category 1 Credit™